Abstracts from the 10th European Breast Cancer Conference: Lapatinib plus trastuzumab, male breast cancer, breast cancer registries

Abstracts from the 10th European Breast Cancer Conference: Lapatinib plus trastuzumab, male breast cancer, breast cancer registries

EMJ

3 years
241 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the Champalimaud Clinical Center, Lisbon, Portugal, provides highlights of abstracts from the conference, including results from the EPHOS-B trial, which was designed to evaluate lapatinib and trastuzumab, alone and in combination, for early HER2-positive breast cancer; and results from the EORTC 10085/TBCRC/BIG/NABG International Male Breast Cancer Program, which was designed to understand pathologic prognostic factors of male breast cancer.



European Medical Journal

Website: http://emjreviews.com/
Twitter: https://twitter.com/EMJReviews
Facebook: https://www.facebook.com/emjreviews
Up Next Autoplay